QCM
LEGN icon

Quantinno Capital Management’s Legend Biotech LEGN Stock Holding History

Quantinno Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$684K Buy
+37,787
New +$720K ﹤0.01% 2476
2025
Q4 		– Sell
-12,388
Closed -$404K – 3194
2025
Q3 		$404K Buy
12,388
+1,628
+15% +$60.1K ﹤0.01% 2206
2025
Q2 		$382K Sell
10,760
-324
-3% -$10.5K ﹤0.01% 1840
2025
Q1 		$376K Buy
+11,084
New +$398K ﹤0.01% 1507

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Quantinno Capital Management's LEGN Position: Q1 2026 in Review

Quantinno Capital Management opened a new position in Legend Biotech (LEGN) in Q1 2026: 37,787 shares worth $684K. The stake represents ﹤0.01% of the portfolio and ranks #2476 among its holdings. This is a return to the name: Quantinno Capital Management previously reported a position in LEGN as recently as Q3 2025.

Quantinno Capital Management first reported a position in LEGN in Q1 2025 and has held it in 4 quarters since. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Quantinno Capital Management held 37,787 shares of Legend Biotech worth $684K as of Q1 2026.
  • Legend Biotech was a new Quantinno Capital Management position in Q1 2026.
  • Legend Biotech made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2476 holding.
  • Quantinno Capital Management first reported a position in Legend Biotech in Q1 2025 and has held it in 4 quarters since.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.